Humana (HUM) Receivables (2009 - 2026)

Humana's Receivables history runs 18 years deep, the most recent figure standing at $324.0 million for Q1 2026.

• In Q1 2026, Receivables fell 92.73% year-over-year to $324.0 million; the TTM figure through Mar 2026 stood at $324.0 million (down 92.73% YoY), while the FY2025 annual figure was $3.4 billion, up 550.66% from the prior year.
• Receivables was $324.0 million for Q1 2026 at Humana, down from $3.4 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $4.5 billion in Q2 2025 to a low of $246.0 million in Q1 2023.
• Historically, Receivables has averaged $1.8 billion across 5 years, with a median of $1.4 billion in 2023.
• The sharpest annual moves came in 2022 and 2026: Receivables surged 1654.69% in 2022, then sank 92.73% in 2026.
• A 5-year view of Receivables shows it stood at $1.9 billion in 2022, then slumped by 71.43% to $530.0 million in 2023, then decreased by 0.57% to $527.0 million in 2024, then jumped by 550.66% to $3.4 billion in 2025, then plunged by 90.55% to $324.0 million in 2026.
• The last three Receivables figures came in at $324.0 million (Q1 2026), $3.4 billion (Q4 2025), and $2.7 billion (Q3 2025), per Business Quant data.